-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$24.751390.96% Upside
PMV Pharmaceuticals, Inc. Frequently Asked Questions
-
What analysts cover PMV Pharmaceuticals, Inc.?
PMV Pharmaceuticals, Inc. has been rated by research analysts at Jefferies, H.C. Wainwright, Oppenheimer, Goldman Sachs in the past 90 days.